29 04 2016

Enlarged Amryt Pharma joins Aim after reverse takeover of Fastnet

Orrick acted for Shore Capital, Stifel and The Davy Group, the investment banking syndicate advising on the reverse takeover of Amryt Pharmaceuticals by cash shell Fastnet Equity plc.


The transaction, financed by the issuance of shares, closed on April 19, 2016. As part of the transaction, Fastnet also raised £10 million via a share placement and changed its name to Amryt Pharma plc.
Amryt is an orphan drug development company that also owns German pharmaceutical company Birken AG (Birken) and Swiss biopharmaceutical company SomPharmaceuticals (Som). Birken has developed a recently approved drug for partial thickness wounds and a promising potential orphan drug candidate to treat epidermolysis bullosa, a rare genetic disease. The group is also developing promising drug candidates to treat acromegaly and Cushing’s disease. 
The Orrick team advising the investment banking syndicate was led by Hilary Winter (Picture) and included Katie Cotton, David Griffiths and Nell Scott (US Securities). ?
  Involved fees earner: Hilary Winter - Orrick; Katie Cotton - Orrick; David Griffiths - Orrick; Nell Scott - Orrick;

LATEST ISSUE
Powered by Share Trading

POPULAR ARTICLES
LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION

09/05/2018

LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION Read about le

LE FONTI AWARDS 2018 CELEBRATES CORPORATE EXCELLENCES IN HONG KONG

29/03/2018

On March 23rd 2018, the world’s leading corporate stars reunited for a special

LE FONTI AWARDS 2017 CELEBRATES CORPORATE EXCELLENCES IN DUBAI

14/12/2017

On December 14th, 2017, the world’s leading corporate stars reunited for a spec

LE FONTI AWARDS 2017 CELEBRATE CORPORATE EXCELLENCES IN LONDON

23/10/2017

On October 20th, 2017, the world’s leading corporate stars reunited for a speci

Le Fonti IAIR Awards Take Hong Kong By Storm

21/03/2017

Hong Kong has become a city of bright expansion, culture, and futuristic innovation. Fr